Ventilator-associated Pneumonia:
Barriers to Best Practices

 

Date:

September 21st @12 PM ET

 

Speaker:

Ashish K. Khanna, , MD, FCCP, FCCM, 

Associate Professor of Anesthesiology 

Wake Forest School of Medicine

Winston-Salem, NC

                        

 

Description:

Ventilator-associated pneumonia (VAP) is a type of hospital-acquired infection that typically develops after more than 48 hours of mechanical ventilation. VAP is a common and serious problem in the intensive care unit that is associated with an increased risk of death.  Additionally, VAP significantly contributes to additional healthcare costs, mainly associated to longer ICU and hospital stay. This webinar will address the best practices for preventing VAP and exam the barriers to implementation

 

Learning Objectives:

Upon completion of this educational activity, the participant will be able to:

  1. Discuss the scope of the problem and current evidence 

  2. Describe the role of subglottic secretions in the pathogenesis of VAP

  3. Discuss the mechanisms of barriers to implementation of best practices in the prevention of VAP 

​

Speaker

Dr. Khanna is an associate professor of anesthesiology at the Wake Forest School of Medicine, and an anesthesiologist/intensivist at the Wake Forest Baptist Medical Center, Winston-Salem, NC. He serves on several editorial boards including the Journal of Critical Care and the Annals of Intensive Care.  Dr. Khanna has published extensively in peer-reviewed journals on several perioperative topics including opioid-related respiratory complications, and the prediction of and monitoring for cardiorespiratory complications within and outside the ICU.  

This continuing education program is sponsored by Covidien LP, a subsidiary of Medtronic, and is an provider approved by
the Commission on Accreditation for Prehospital Continuing Education

Continuing Education for Physicians, Nurses, and Respiratory Therapists

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by ACCME for 1 AMA PRA Category 1 Creditâ„¢. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.

 

Support for this educational activity from Medtronic